1-4 of 4
Linh Nguyen
Close
Save search
Sort by
Journal Articles

A Phase 2/3, multicenter, randomized, open-label study evaluating the efficacy and safety of etentamig and daratumumab compared to daratumumab, lenalidomide, and dexamethasone in frailer transplant-ineligible patients with newly diagnosed multiple myeloma

Free
Salomon Manier, Noemí Puig, Xavier Leleu, Albert Oriol, Cyrille Hulin, Ramon García-Sanz, Jill Corre, Jesus San-Miguel, Thierry Facon, Hans Lee, Peter Forsberg, Kaustav Chatterjee, Anders Svensson, Chetasi Talati, Sunny He, Thomas Doerr, Emma Arriola, Myles Dillon, Jennifer Lin, Linh Nguyen, Fan Wang, María-Victoria Mateos
Journal: Blood
Blood (2025) 146 (Supplement 1): 2288.
https://doi.org/10.1182/blood-2025-2288
Published: 2025
Journal Articles

Preliminary Results from a Phase 1b/2 Open-Label, Multicenter, Dose Optimization Clinical Study of the Safety, Tolerability, and Pharmacokinetic (PK) and Pharmacodynamic (PD) Profiles of Cfi-400945 As a Single Agent or in Combination with Azacitidine in Patients (Pts) with Acute Myeloid Leukemia, Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia (TWT-202)

Free
Brian A. Jonas, Karen Yee, Alice Mims, Paul B. Koller, Joseph Brandwein, Gail J. Roboz, Glenn Michelson, Linh Nguyen, Mark R Bray, Emily Roberts-Thomson, Roger Sidhu, Gautam Borthakur
Journal: Blood
Blood (2023) 142 (Supplement 1): 4294.
https://doi.org/10.1182/blood-2023-182027
Published: 2023
Journal Articles

Preliminary Results from a Phase 2 Open-Label, Multicenter, Dose Optimization Clinical Study of the Safety, Tolerability, and Pharmacokinetic (PK) and Pharmacodynamic (PD) Profiles of Cfi-400945 As a Single Agent or in Combination with Azacitidine or Decitabine in Patients with Acute Myeloid Leukemia, Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia (TWT-202)

Free
Brian A. Jonas, Karen Yee, Paul B. Koller, Joseph Brandwein, Alice S. Mims, Glenn C. Michelson, Linh Nguyen, Mark R Bray, Emily L Roberts-Thomson, Gautam Borthakur
Journal: Blood
Blood (2022) 140 (Supplement 1): 9076–9077.
https://doi.org/10.1182/blood-2022-158370
Published: 2022
Journal Articles

First Line Chronic Lymphocytic Leukemia Immunochemotherapy for the Elderly Patients over 79 Years Is Feasible, and Achieves Good Results: A Filo Retrospective Study

Free
Godelieve Meunier, Loïc Ysebaert, MD PhD, Phi Linh Nguyen-Thi, MD PhD, Stephane Lepretre, MD, Anne Quinquenel, MD, Jehan Dupuis, MD, Richard Lemal, MD, Therese Aurran-Schleinitz, MD, Cecile Tomowiak, MD, Florence Cymbalista, MD PhD, Marie Sarah Dilhuydy, MD, Annie Brion, MD, Pierre Morel, MD, Bruno Cazin, MD, Veronique Leblond, MD PhD, Guillaume Cartron, MD PhD, Daniel Ré, MD, Marie C Bene, PharmSciD, PhD, Anne-Sophie Michallet, MD, Pierre Feugier, MD PhD
Journal: Blood
Blood (2015) 126 (23): 4170.
https://doi.org/10.1182/blood.V126.23.4170.4170
Published: 2015